Norris Medicines Limited, a active public limited company, was established on 07 September 1990 in Ankleshwar, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24230GJ1990PLC086581. Registered under ROC Roc Ahmedabad. it is listed on BSE: 524414. It has an authorized capital of ₹10.10 Cr and a paid-up capital of ₹9.93 Cr.
It upholds a compliant status. Employing 18 professional, Its leadership includes Praveenchand Bafna (Director), Vimal Dhirendra Shah (Director), Angamuthu Vadivel (Director). Past directors included Navnit Jethabhai Patel, Nakul Upadhyaya Lalitkumar, Mahapatra Susmita. It holds ₹3.57 Cr open charges and ₹7.75 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 801/P, Gidc,, Ankleshwar, Gujarat, 393002.
L24230GJ1990PLC086581
086581
07 September 1990
₹10.10 Cr
₹9.93 Cr
Roc Ahmedabad
Listed (BSE: 524414)
Active
Explore comprehensive insights into Norris Medicines Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Praveenchand Bafna | Director | 24 Aug 2024 | Current |
| Vimal Dhirendra Shah | Director | 29 Dec 2023 | Current |
| Angamuthu Vadivel | Director | 29 Apr 2024 | Current |
| Sathya Venkatachalam | Additional Director | 25 Sep 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 09 Feb 2019 | Past |
| Pramod Abcsdd | Director | 20 Feb 2012 | Past |
| Pramod Abcsdd | Additional Director | 25 Sep 2020 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 01 Apr 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Norris Medicines Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2024, Norris Medicines had a promoter holding of 34.01% and a public holding of 65.98%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹35,700,000.00
₹77,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jun 2014 | City Union Bank Limited | ₹3.57 Cr | Open |
| 01 Nov 1995 | Dena Bank | ₹7.75 Cr | Satisfied |
Explore comprehensive loan charge details -
Norris Medicines has a workforce of 18 employees as of Mar 06, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Norris Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Norris Medicines's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Norris Medicines Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Sathya Venkatachalam was appointed as a Additional Director was appointed as a Additional Director on 25 Sep 2024 & has been associated with this company since 1 year 2 months . was completed.
The activity Praveenchand Bafna was appointed as a Director was appointed as a Director on 24 Aug 2024 & has been associated with this company since 1 year 3 months . was completed.
Priyanka Lohiya was appointed as a Company Secretary was appointed as a Company Secretary on 23 Jul 2024 & has been associated with this company since 1 year 4 months . was recorded as a recent event.
The activity Angamuthu Vadivel was appointed as a Director was appointed as a Director on 29 Apr 2024 & has been associated with this company since 1 year 7 months . was completed.
Progress on Norris Medicines Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
The CIN of Norris Medicines Limited is L24230GJ1990PLC086581.
Norris Medicines Limited is headquartered at Plot No. 801/P, Gidc,, Ankleshwar, Gujarat, 393002.
Norris Medicines Limited was incorporated on 07 September 1990.
The current directors of Norris Medicines Limited are
The primary industry of Norris Medicines Limited is Manufacturing.
Norris Medicines Limited is listed. It is listed on BSE: 524414.
The authorized capital of Norris Medicines Limited is ₹10.10 Cr, and the paid-up capital is ₹9.93 Cr.
The compliance status of Norris Medicines Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX